ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Apr 7, 2015
Insider Transaction Report
Form 4
NARINE JEENARINE
Director10% Owner
Transactions
- Other
Warrants
2015-04-03−40,000,000→ 0 total(indirect: By LLC)Exercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (40,000,000 underlying) - Other
Warrants
2015-04-03−6,726,999→ 0 total(indirect: By LLC)Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (6,726,999 underlying) - Other
Warrants
2015-04-03−4,000,000→ 0 total(indirect: By LLC)Exercise: $0.06From: 2011-04-25Exp: 2018-04-25→ Common Stock (4,000,000 underlying) - Other
Warrants
2015-04-03+9,910,532→ 9,910,532 totalExercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (9,910,532 underlying) - Other
Warrants
2015-04-03−2,454,665→ 0 total(indirect: By LLC)Exercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (2,454,665 underlying)
Footnotes (3)
- [F1]Disposition of warrants to its members
- [F2]Jeenarine Narine is an equity owner and executive officer of each of Epic Pharma. LLC ("EP"), and Epic Investments, LLC ("EI")(which is controlled by EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- [F3]Jeenarine Narine is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which is a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.